Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Novavax Is a Short-Term Trade in a Long-Term Paradigm

By Josh Enomoto, InvestorPlace Contributor

Although NVAX stock has some near-term catalysts to rise on, the longer-term backdrop favors the vaccine competitors.

7 Cryptos to Keep Under Scrutiny Following the Evergrande News

By Josh Enomoto, InvestorPlace Contributor

With a massive headwind in China imposing a dark cloud over cryptos, it may be time to consider trimming some exposure.

7 Robinhood Stocks to Buy for Newbie Investors

By Josh Enomoto, InvestorPlace Contributor

Although Robinhood stocks often entail speculative ventures, investing newcomers should consider the app's safer fixations.

Cardano Craziness Proves We Need to Kill Some Sacred Cows

By Josh Enomoto, InvestorPlace Contributor

With Cardano taking a massive hit in the September crash in the cryptocurrency market, it’s time for some serious reflection.

The Polkadot Fallout Might Prove the Disassociation Thesis Wrong

By Josh Enomoto, InvestorPlace Contributor

While crypto advocates would like to think that individual coins like Polkadot act on their own fundamentals, the truth says otherwise.

Whether It’s Fundamentals or Technicals, ContextLogic Stock Looks Scary

By Josh Enomoto, InvestorPlace Contributor

With technical pressures and fundamental questions weighing on WISH stock, there doesn’t appear to be much reason to bet on it.

7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink

By Josh Enomoto, InvestorPlace Contributor

Thanks to the coronavirus pandemic, many people are rethinking the medical sector, boding well for healthcare stocks.

It’s Time to Start Thinking Seriously About Vaxart

By Josh Enomoto, InvestorPlace Contributor

While VXRT stock is risky due to underlying clinical challenges, the evolving nature of Covid-19 makes it worth consideration.

Greenidge Generation’s Bitcoin Bet Is Extremely Speculative

By Josh Enomoto, InvestorPlace Contributor

Although GREE stock is backed by an intriguing concept of carbon-neutral crypto mining, the narrative is incredibly risky. Greenidge Generation shares are only suitable for gamblers after its apples-and-oranges reverse merger.

The Fairy Tale Ending for General Electric May Get Delayed

By Josh Enomoto, InvestorPlace Contributor

Although GE stock is buoyed by a return of sentiment for air travel, the magnitude of such a tailwind remains a big question.

Load More